Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Intrathecal Gene Therapy For SLC13A5 Citrate Transporter Disorder
Not Applicable
Not yet recruiting
- Conditions
- SLC13A5 Citrate Transporter Disorder
- Interventions
- First Posted Date
- 2025-08-03
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- TESS Research Foundation
- Target Recruit Count
- 2
- Registration Number
- NCT07102524
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
SLC13A5 Deficiency Natural History Study - United States Only
- Conditions
- Citrate Transporter DeficiencyEpilepsyRare DiseasesMovement DisordersGenetic DisorderSLC13A5 DeficiencyEIEE25Kohlschutter-Tonz Syndrome (Non-ROGDI)Citrate Transporter DisorderDEE25
- First Posted Date
- 2023-11-22
- Last Posted Date
- 2025-08-05
- Lead Sponsor
- TESS Research Foundation
- Target Recruit Count
- 17
- Registration Number
- NCT06144957
- Locations
- 🇺🇸
Lucille Packard Children's Hospital, Stanford University, Palo Alto, California, United States
🇺🇸Brown University, Providence, Rhode Island, United States
🇺🇸University of Texas Southwestern Dallas, Dallas, Texas, United States
SLC13A5 Deficiency Natural History Study - Remote Only
- Conditions
- Citrate Transporter DeficiencyEpilepsyRare DiseasesMovement DisordersGenetic DisorderSLC13A5 DeficiencyEIEE25Kohlschutter-Tonz Syndrome (non-ROGDI)17p13.1 Deletions Confined to SLC13A5 GeneCitrate Transporter Disorder
- First Posted Date
- 2020-12-23
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- TESS Research Foundation
- Target Recruit Count
- 20
- Registration Number
- NCT04681781
- Locations
- 🇺🇸
Lucille Packard Children's Hospital, Stanford University, Palo Alto, California, United States
News
No news found